Photodynamic therapy with the silicon phthalocyanine Pc 4 induces apoptosis in mycosis fungoides and sezary syndrome

Advances in Hematology

Volumn 2010, Issue , 2010, Pages

  Baron, Elma D ^a,c   Lam, Minh ^a   Lee, Yoojin ^a   Deng, Min ^a   Hsia, Andrew H ^a   Morrissey, Kelly A ^a   Yan, Chunlin ^a,b   Azzizudin, Kashif ^a   Oleinick, Nancy L ^a   McCormick, Thomas S ^a   Cooper, Kevin D ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD7 ANTIGEN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PROTEIN BCL 2; SILICON DERIVATIVE; SILICON PHTHALOCYANINE PC 4; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGHT DAMAGE; MONOCYTE; MYCOSIS FUNGOIDES; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN BIOPSY;

EID: 79251580954     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2010/896161     Document Type: Article

References (24)

1. Lee T. K., Baron E. D., Foster T. H., Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy Journal of Biomedical Optics 2008 13 3 1 3
2. Garcia-Zuazaga J., Cooper K. D., Baron E. D., Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer Expert Review of Anticancer Therapy 2005 5 5 791 800
3. Moriwaki S.-I., Misawa J., Yoshinari Y., Yamada I., Takigawa M., Tokura Y., Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin) Photodermatology Photoimmunology and Photomedicine 2001 17 5 241 243
4. Ahmadi S., McCarron P. A., Donnelly R. F., Woolfson A. D., McKeena K., Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study Experimental Dermatology 2004 13 7 445 451
5. Oleinick N. L., Antunez A. R., Clay M. E., Rihter B. D., Kenney M. E., New phthalocyanine photosensitizers for photodynamic therapy Photochemistry and Photobiology 1993 57 2 242 247
6. Trivedi N. S., Wang H.-W., Nieminen A.-L., Oleinick N. L., Izatt J. A., Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy Photochemistry and Photobiology 2000 71 5 634 639
7. Lam M., Oleinick N. L., Nieminen A.-L., Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells: reactive oxygen species and mitochondrial inner membrane permeabilization Journal of Biological Chemistry 2001 276 50 47379 47386
8. Wong T.-W., Tracy E., Oseroff A. R., Baumann H., Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors Cancer Research 2003 63 13 3812 3818
9. Davies M. J., Singlet oxygen-mediated damage to proteins and its consequences Biochemical and Biophysical Research Communications 2003 305 3 761 770
10. Oleinick N. L., Evans H. H., The photobiology of photodynamic therapy: cellular targets and mechanisms Radiation Research 1998 150 5 S146 S156
11. Henderson B. W., Gollnick S. O., Horspool W., Lenci F., Mechanistic principles of photodynamic therapy CRC Handbook of Organic Photochemistry and Photobiology 2003 New York, NY, USA CRC Press 145-2 145-25
12. Xue L.-Y., Chiu S.-M., Oleinick N. L., Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4 Oncogene 2001 20 26 3420 3427
13. Henderson B. W., Daroqui C., Tracy E., Vaughan L. A., Loewen G. M., Cooper M. T., Baumann H., Cross-linking of signal transducer and activator of transcription 3-A molecular marker for the photodynamic reaction in cells and tumors Clinical Cancer Research 2007 13 11 3156 3163
14. Xue L.-Y., Chiu S.-M., Fiebig A., Andrews D. W., Oleinick N. L., Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer Pc 4 Oncogene 2003 22 58 9197 9204
15. Kim H.-R. C., Luo Y., Li G., Kessel D., Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection Cancer Research 1999 59 14 3429 3432
16. Usuda J., Chiu S.-M., Murphy E. S., Lam M., Nieminen A.-L., Oleinick N. L., Domain-dependent photodamage to Bcl-2: a membrane anchorage region is needed to form the target of phthalocyanine photosensitization Journal of Biological Chemistry 2003 278 3 2021 2029
17. Zhang C., Ao Z., Seth A., Schlossman S. F., A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells Proceedings of the National Academy of Sciences of the United States of America 1996 95 11 6290 6295
18. Ke M. S., Xue L. Y., Feyes D. K., Uptake of the silicon phthalocyanine Pc 4 and photodynamic dose-response relationships in A-431 vs. jurkat cells Journal of Investigative Dermatology 2002 119 1 336
19. Willemze R., Jaffe E. S., Burg G., Cerroni L., Berti E., Swerdlow S. H., Ralfkiaer E., Chimenti S., Diaz-Perez J. L., Duncan L. M., Grange F., Harris N. L., Kempf W., Kerl H., Kurrer M., Knobler R., Pimpinelli N., Sander C., Santucci M., Sterry W., Vermeer M. H., Wechsler J., Whittaker S., Meijer C. J. L. M., WHO-EORTC classification for cutaneous lymphomas Blood 2005 105 10 3768 3785
20. Rappl G., Muche J. M., Abken H., Sterry W., Tilgen W., Ugurel S., Reinhold U., CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Szary syndrome Journal of the American Academy of Dermatology 2001 44 3 456 461
21. Stevens S. R., Baron E. D., Masten S., Cooper K. D., Circulating CD 4+ CD7 - lymphocyte burden and rapidity of response: predictors of outcome in the treatment of szary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis Archives of Dermatology 2002 138 10 1347 1350
22. Sugiyama H., Gyulai R., Toichi E., Garaczi E., Shimada S., Stevens S. R., McCormick T. S., Cooper K. D., Dysfunctional blood and target tissue CD 4+ CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation Journal of Immunology 2005 174 1 164 173
23. Dummer R., Michie S. A., Kell D., Gould J. W., Haeffner A. C., Smoller B. R., Warnke R. A., Wood G. S., Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates Journal of Cutaneous Pathology 1995 22 1 11 17
24. Mao X., Orchard G., Lillington D. M., Child F. J., Vonderheid E. C., Nowell P. C., Bagot M., Bensussan A., Russell-Jones R., Young B. D., Whittaker S. J., BCL2 and JUNB abnormalities in primary cutaneous lymphomas British Journal of Dermatology 2004 151 3 546 556